Best of 2024: Top 10 Insights In Clinical Supply Chain & Logistics

#1 - How To Prevent And Manage Temperature Excursions In Clinical Trials

Temperature excursions can have devastating effects on drug product for clinical trials. Here are some ways to avoid them and protect the cold chain.

#2 - Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials

Learn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.

#3 - FDA Finalizes Guidance About Delaying, Denying, Limiting, Or Refusing An Inspection

The FDA has finalized a guidance on the circumstances that constitute delaying, denying, limiting, or refusing a drug or device inspection. View the key takeaways. 

#4 - The Future Of Drug Storage & Distribution

Consider these strategies when anticipating and mitigating disruptions, and how future innovations and trends will continue to shape the logistics industry.

#5 - When Does GMP Matter In Non-GMP Settings?

Would you ever need to follow GMP standards in workspaces where GMP is not required or possible? This article digs into why, when, and how to follow the principles of GMP.

#6 -A Prescription For Success: Treating Deficiencies In Employee Training And Mentorship

Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.

#7 -Donating Surplus Clinical Trial Supplies Is Sustainability's “Low-Hanging Fruit”

ClinOps professionals know all too well the waste that occurs with leftover trial kits that are destroyed at the end of the trial. Explore donation as a way to give those kits a second life.

#8 - Factors In Developing Injectable Drug Placebo Formulations For Pharmaceutical Clinical Trials

Review the factors that pharmaceutical scientists must consider when formulating placebos for injectable drugs to ensure the reliability and validity of clinical trial outcomes.

#9 - Do ClinOps Professionals Understand The CAR-T Supply Chain?

Lee Clough RN, HP, of Novartis talks about the importance of understanding the nuances associated with collecting and shipping autologous material (i.e., CAR-Ts) for clinical trials.

#10 - Providing Drug Supply Support In Complex Environments Through IRT

Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.